Abstract
Introduction/BackgroundARTISTRY-7 will evaluate the novel engineered cytokine nemvaleukin alfa (nemvaleukin, ALKS 4230) in patients with gynaecological cancers. Epithelial ovarian cancer (EOC) is the 7th most common cause of cancer mortality...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have